OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS)
|
|
|
- CAS-Nr.
- 104721-52-0
- Englisch Name:
- OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS)
- Synonyma:
- Ofloxacin Impurity F;Bifeprunox Impurity 39;Ofloxacin EP IMpurity F;Ofloxacin Impurity 6（HCl）;Ofloxacin N-Oxide Acetic Acid Salt;4-[(RS)-6-Carboxy-9-fluoro-3-methyl;Ofloxacin EP Impurity F (Ofloxacin N-Oxide);OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS);Ofloxacin Impurity 6(Ofloxacin EP Impurity F);Ofloxacin N-Oxide Acetic Acid Salt (Impurity F)
- CBNumber:
- CB2496887
- Summenformel:
- C18H20FN3O5
- Molgewicht:
- 377.37
- MOL-Datei:
- 104721-52-0.mol
|
OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS) Eigenschaften
- Schmelzpunkt:
- 215-2200C (dec.)
- storage temp.
- Amber Vial, -20°C Freezer
- L?slichkeit
- DMSO (Very Slightly, Heated), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 5.19±0.40(Predicted)
- Farbe
- White to Off-White
- Stabilit?t:
- Light Sensitive
Sicherheit
OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS) Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Off-White Solid
Verwenden
A metabolite of Ofloxacin
OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 48)Lieferanten
104721-52-0()Verwandte Suche:
- 4-(6-carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide
- OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS)
- 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Aci
- 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Acetic Acid Salt
- Ofloxacin N-Oxide Acetic Acid Salt (Mixture of Diastereomers)
- Ofloxacin EP IMpurity F
- Ofloxacin N-Oxide Acetic Acid Salt
- Ofloxacin EP Impurity F (Ofloxacin N-Oxide)
- Ofloxacin N-Oxide Acetic Acid Salt (Impurity F)
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-
- 4-(6-carboxy-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide hydrochloride
- Ofloxacin Impurity 6(Ofloxacin EP Impurity F)
- 4-[(RS)-6-Carboxy-9-fluoro-3-methyl
- Ofloxacin Impurity 6（HCl）
- Ofloxacin Impurity F
- Levofloxacin Impurity 25（Ofloxacin EP Impurity F）
- 4-(6-Carboxy-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide (Ofloxacin Impurity)
- Ofloxacin EP Impurity F(Levofloxacin Impurity 25)
- Bifeprunox Impurity 39
- 104721-52-0
- C20H24FN3O7
- Intermediates & Fine Chemicals
- Metabolites & Impurities
- Pharmaceuticals
- Various Metabolites and Impurities
